Igc pharma inc IGC.US 總覽分析

IGC 投資分析

IGC 近期報酬表現

與 IGC 同產業的標的表現

• RITR Reitar logtech holdings ltd

  價值 -趨勢 3 分波段 -籌碼 -股利 1 分

  查看更多
• ECG Everus construction group inc
• OESX Orion energy systems, incorporation
• NX Quanex building products corporation
• CTRI Centuri holdings inc
• PRIM Primoris services corporation
• CSL Carlisle companies, incorporated
• BBCP Concrete pumping holdings inc
• ACM Aecom
• FLR Fluor corporation

IGC 公司資訊

IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer's disease. The Company's flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. The Company operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer's by targeting A? plaques, a key disease hallmark. The Company's IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. Its IGC-M3 focuses on early intervention by inhibiting A? plaque formation, potentially slowing cognitive decline. Its LMP is designed to target multiple hallmarks of Alzheimer's disease, including A? plaques and neurofibrillary tangles for a comprehensive therapeutic effect. It seeks to leverage artificial intelligence (AI) for Alzheimer's research.